-
1
المؤلفون: Daniel Prieto-Alhambra, Irene Petersen, Antonella Delmestri, Cyrus Cooper, T P van Staa, Samuel Hawley, Muhammad Javaid, Elisa Martín-Merino, S Khalid, Ana Llorente-García, Arturo Álvarez-Gutiérrez, Andrew Judge
المساهمون: Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
المصدر: Martín-Merino, E, Petersen, I, Hawley, S, Álvarez-Gutierrez, A, Khalid, S, Llorente-Garcia, A, Delmestri, A, Javaid, M K, Van Staa, T P, Judge, A, Cooper, C & Prieto-Alhambra, D 2018, ' Risk of venous thromboembolism among users of different anti-osteoporosis drugs : a population-based cohort analysis including over 200,000 participants from Spain and the UK ', Osteoporosis International, vol. 29, no. 2, pp. 467–478 . https://doi.org/10.1007/s00198-017-4308-5
Osteoporosis International, 29(2), 467. Springer Londonمصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, Thiophenes/adverse effects, Cohort Studies, 0302 clinical medicine, Strontium ranelate, Teriparatide, 80 and over, Electronic health records, 030212 general & internal medicine, Bone Density Conservation Agents/adverse effects, Denosumab/adverse effects, Aged, 80 and over, Alendronate, Bone Density Conservation Agents, Diphosphonates, United Kingdom/epidemiology, Hazard ratio, Alendronate/adverse effects, Venous Thromboembolism, Pharmacoepidemiology, Middle Aged, Primary care, Diphosphonates/adverse effects, Denosumab, Cohort, Spain/epidemiology, Female, medicine.drug, Cohort study, Venous thromboembolism, medicine.medical_specialty, 030209 endocrinology & metabolism, Thiophenes, Risk Assessment, Bazedoxifene, 03 medical and health sciences, Primary Health Care/methods, Teriparatide/adverse effects, Internal medicine, medicine, Humans, Anti-osteoporosis medication, Risk Assessment/methods, Aged, Primary Health Care, business.industry, United Kingdom, Spain, Venous Thromboembolism/chemically induced, business
وصف الملف: application/pdf